| Lipid Composition for FAC-201 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-Phosphatidylcholine | 1.485 | 1.14 | 99 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE) | 0.015 | 0.01 | 1 |
| Total | 1.500 µmol/vial | 1.15 mg/vial | 100 |
| Lipid Composition for FAC-202 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-Phosphatidylcholine | 0.960 | 0.74 | 64 |
| Cholesterol | 0.525 | 0.20 | 35 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE) | 0.015 | 0.01 | 1 |
| Total | 1.500 µmol/vial | 0.95 mg/vial | 100 |
| Lipid Composition for FAC-203 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.735 | 0.58 | 49 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 0.450 | 0.33 | 30 |
| Cholesterol | 0.300 | 0.12 | 20 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE) | 0.015 | 0.01 | 1 |
| Total | 1.500 µmol/vial | 0.01 mg/vial | 100 |
| Lipid Composition for FAC-204 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-Phosphatidylcholine | 1.485 | 1.14 | 99 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE) | 0.015 | 0.02 | 1 |
| Total | 1.500 µmol/vial | 1.16 mg/vial | 100 |
| Lipid Composition for FAC-205 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-Phosphatidylcholine | 0.960 | 0.74 | 64 |
| Cholesterol | 0.525 | 0.20 | 35 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE) | 0.015 | 0.02 | 1 |
| Total | 1.500 µmol/vial | 0.96 mg/vial | 100 |
| Lipid Composition for FAC-206 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.735 | 0.58 | 49 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 0.450 | 0.33 | 30 |
| Cholesterol | 0.300 | 0.12 | 20 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE) | 0.015 | 0.02 | 1 |
| Total | 1.500 µmol/vial | 1.05 mg/vial | 100 |
